Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 3/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | FNTA | P49354 | 1/20 | 0.48 |
| ▸ | FNTB | P49356 | 1/20 | 0.48 |
| ▸ | CTSD | P07339 | 1/20 | 0.48 |
| ▸ | CASP2 | P42575 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | NSD2 | O96028 | 1/20 | 0.36 |
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7527834 | 0.98 | HDAC3 (0.48) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL8087887 | 0.98 | HDAC3 (0.48) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL3477319 | 0.86 | FNTA (0.46) | FNTAFNTBCASP2CES2CES1 | |
| SCHEMBL7180177 | 0.84 | HSP90AA1 (0.54) | FNTAFNTBCASP2CES2CES1 | |
| SCHEMBL11649466 | 0.82 | HSP90AA1 (0.57) | CASP2CES2CES1TSHREPHX2 | |
| SCHEMBL21060856 | 0.82 | HSP90AA1 (0.57) | CASP2CES2CES1TSHREPHX2 | |
| SCHEMBL7184916 | 0.82 | HSP90AA1 (0.57) | CASP2CES2CES1TSHREPHX2 | |
| SCHEMBL7185340 | 0.82 | HSP90AA1 (0.57) | CASP2CES2CES1TSHREPHX2 | |
| SCHEMBL28194397 | 0.82 | HSP90AA1 (0.52) | FNTAFNTBCASP2CES2CES1 | |
| SCHEMBL7558419 | 0.82 | HDAC3 (0.52) | HDAC3HDAC1HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6583130-B1 | Substituted with acyl, oxycarbonyl, aminocarbonyl, sulfonyl, or aminosulfonyl; inhibit steroid sulfatase, do not exhibit any estrogenic effect and will not yield any estrogenic products on hydrolysis; treatment of estrogen-dependent tumors | SCHERING AG (DE) | 2003-06-24 | — | — | US | claimed |
| EP-2386538-B1 | N-(1-HYDROXYETHYL)CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME | SHOWA DENKO KK (JP) | 2015-07-29 | — | — | EP | disclosed |
| US-8697912-B2 | N-(1-hydroxyethyl) carboxamide compound and process for producing same | SHOWA DENKO K.K. (JP) | 2014-04-15 | — | — | US | disclosed |
| US-8383745-B2 | Method for producing N-methyl-N-vinylacetamide having improved stability and polymerizability | SHOWA DENKO K.K. (JP) | 2013-02-26 | — | — | US | disclosed |
| US-20110294974-A1 | N-(1-HYDROXYETHYL ) CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME | SHOWA DENKO K.K. (JP) | 2011-12-01 | — | — | US | disclosed |
| EP-2386538-A1 | N-(1-HYDROXYETHYL)CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME | Showa Denko K.K. (JP) | 2011-11-16 | — | — | EP | disclosed |
| US-20100280204-A1 | METHOD FOR PRODUCING N-METHYL-N-VINYLACETAMIDE HAVING IMPROVED STABILITY AND POLYMERIZABILITY | SHOWA DENKO K.K. (JP) | 2010-11-04 | — | — | US | disclosed |
| EP-2239250-A1 | METHOD FOR PRODUCING N-METHYL-N-VINYLACETAMIDE HAVING IMPROVED STABILITY AND POLYMERIZABILITY | Showa Denko K.K. (JP) | 2010-10-13 | — | — | EP | disclosed |
| EP-1291397-B1 | INK SET FOR INK-JET RECORDING | SEIKO EPSON CORP (JP) | 2006-12-27 | — | — | EP | disclosed |
| US-6767090-B2 | Ink set for ink-jet recording | SEIKO EPSON CORPORATION (JP) | 2004-07-27 | — | — | US | disclosed |
| WO-1998039316-A1 | N-HYDROXY 4-SULFONYL BUTANAMIDE COMPOUNDS | MONSANTO COMPANY (US) | 1998-09-11 | — | — | WO | disclosed |
| US-5789619-A | USED AS COAGULANTS, LIQUID ABSORBENTS, THICKENERS | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1998-08-04 | — | — | US | disclosed |
| EP-0812311-A1 | HIGHLY POLYMERIZABLE N-VINYLCARBOXYLIC ACID AMIDE AND PRODUCTION PROCESS THEREOF | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1997-12-17 | — | — | EP | disclosed |
| EP-0799820-A1 | Process producing n-(1-alkoxyethyl)carboxylic amides | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1997-10-08 | — | — | EP | disclosed |
| WO-1997024315-A1 | HIGHLY POLYMERIZABLE N-VINYLCARBOXYLIC ACID AMIDE AND PRODUCTION PROCESS THEREOF | SHOWA DENKO K.K. (JP) | 1997-07-10 | — | — | WO | disclosed |
| EP-0510246-B1 | Use of fine particulate crosslinked type n-vinylamide resin microgel | SHOWA DENKO KK (JP) | 1996-09-25 | — | — | EP | disclosed |
| US-5338815-A | Used in thickeners, dispersion stabilizers and lubricants | SHOWA DENKO K.K. (JP) | 1994-08-16 | — | — | US | disclosed |
| US-5280095-A | N-vinylcarboxylic acid amine resin | SHOWA DENKO K.K. (JP) | 1994-01-18 | — | — | US | disclosed |
| EP-0510246-A1 | Use of fine particulate crosslinked type n-vinylamide resin microgel | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1992-10-28 | — | — | EP | disclosed |
| US-3957860-A | SULFAMIC ACID | CIBA-GEIGY AG (CH) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294974-A1 | N-(1-HYDROXYETHYL ) CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME | ADH1A, ADH1C, CNKSR1 | HDAC3 150/4885HDAC1 20/4885HDAC2 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.